Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Omalizumab for asthma.

Strunk RC, Bloomberg GR.

N Engl J Med. 2006 Jun 22;354(25):2689-95. Review. No abstract available.

2.

[Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].

Michils A, Sternon J.

J Pharm Belg. 2006;61(3):83-7. Review. French.

PMID:
17058881
3.

[Omalizumab. A monoclonal antibody against IgE].

Hennemann A.

Med Monatsschr Pharm. 2004 Dec;27(12):404-7. Review. German. No abstract available.

PMID:
15646688
4.

Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.

Nowak D.

Respir Med. 2006 Nov;100(11):1907-17. Epub 2006 Sep 1. Review.

5.

Omalizumab for asthma: indications, off-label uses and future directions.

Ben-Shoshan M.

Recent Pat Inflamm Allergy Drug Discov. 2010 Nov;4(3):183-92. Review.

PMID:
20807194
6.

Anti-IgE in allergic asthma and rhinitis: an update.

Morjaria JB, Gnanakumaran G, Babu KS.

Expert Opin Biol Ther. 2007 Nov;7(11):1739-47. Review.

PMID:
17961096
7.

Omalizumab in the treatment of severe asthma: efficacy and current problems.

Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.

Ther Adv Respir Dis. 2008 Dec;2(6):409-21. doi: 10.1177/1753465808100431. Review.

PMID:
19124386
8.

[Pneumology. Anti-IgE antibodies in the treatment of asthma].

Leuenberger P, Sauty A, Rochat T.

Rev Med Suisse. 2007 Jan 10;3(93):56-9. Review. French.

PMID:
17354662
9.

Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.

Hayden ML.

J Am Acad Nurse Pract. 2007 Sep;19(9):439-49. Review.

PMID:
17760568
10.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
11.

Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.

Dodig S, Richter D, Cepelak I, Benko B.

Acta Pharm. 2005 Jun;55(2):123-38. Review.

PMID:
16179127
12.

[Pratical aspects of anti-Ige therapy in severe allergic asthma].

Taramarcaz P, Hauser C, Rochat T.

Rev Med Suisse. 2007 Apr 25;3(108):1050-2, 1054-5. Review. French.

PMID:
17552257
13.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
14.

An overview of EPR3 asthma guidelines: what's different?

Lang DM.

Allergy Asthma Proc. 2007 Nov-Dec;28(6):620-7. doi: 10.2500/aap.2007.28.3065. Review.

PMID:
18201424
15.

Asthma 2008: targeting immunoglobulin E to achieve disease control.

Prenner BM.

J Asthma. 2008 Aug;45(6):429-36. doi: 10.1080/02770900802085485. Review.

PMID:
18612893
16.

Anti-IgE in severe persistent allergic asthma.

Fox H.

Respirology. 2007 Nov;12 Suppl 3:S22-8; discussion S45-7. Review.

PMID:
17956516
17.

Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.

D'Amato G.

Eur J Pharmacol. 2006 Mar 8;533(1-3):302-7. Epub 2006 Feb 7. Review.

PMID:
16464445
18.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
19.

[Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].

Targowski T, From S.

Pol Merkur Lekarski. 2003 Jan;14(79):65-8. Review. Polish.

PMID:
12712834
20.

Immunoglobulin E blockade in the treatment of asthma.

Kuhn R.

Pharmacotherapy. 2007 Oct;27(10):1412-24. Review.

PMID:
17896896

Supplemental Content

Support Center